The 2018–2020 Ebola Outbreak in the Democratic Republic of Congo: A Better Response Had Been Achieved Through Inter-State Coordination in Africa

Autor: Guetiya Wadoum RE, Sevalie S, Minutolo A, Clarke A, Russo G, Colizzi V, Mattei M, Montesano C

Publikováno v: Risk Management and Healthcare Policy, Vol Volume 14, Pp 4923-4930 (2021)

Raoul Emeric Guetiya Wadoum,1 Stephen Sevalie,2 Antonella Minutolo,3 Andrew Clarke,4,5 Gianluca Russo,6 Vittorio Colizzi,7 Maurizio Mattei,8 Carla Montesano8 1Department of Public Health, Microbiology and Immunology, Ernest Bai Koroma University of S

Externí odkaz: https://doaj.org/article/e672b29c43e546c59acdc5662a859881

Integrated analyses of the transmission history of SARS-CoV-2 and its association with molecular evolution of the virus underlining the pandemic outbreaks in Italy, 2019-2023.

Autor: Cella E; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA., Fonseca V; Department of Exact and Earth Sciences, University of the State of Bahia, Salvador, Brazil., Branda F; Unit of Medical Statistics and Molecular Epidemiology, University of Campus Bio-Medico di Roma, Rome, Italy., Tosta S; Programa Interunidades de Pós-Graduação em Bioinformática, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Moreno K; Programa Interunidades de Pós-Graduação em Bioinformática, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Schuab G; Laboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil., Ali S; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA., Slavov SN; Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Butantan Institute, São Paulo, Brazil., Scarpa F; Department of Biomedical Sciences, University of Sassari, Sassari, Italy., Santos LA; Bahiana School of Medicine and Public Health, Salvador, Bahia, Brazil., Kashima S; Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Wilkinson E; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa., Tegally H; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa., Mavian C; Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA; Global Health Program Smithsonian's National Zoo & Conservation Biology Institute, DC, USA., Borsetti A; National HIV/AIDS Research Center (CNAIDS), Istituto Superiore di Sanità, Rome, Italy., Caccuri F; Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Brescia, Italy., Salemi M; Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA., de Oliveira T; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa., Azarian T; Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA., de Filippis AMB; Laboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil., Alcantara LCJ; Fundação Oswaldo Cruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil., Ceccarelli G; Infectious Diseases Department, Azienda Ospedaliero Universitaria Policlinico Umberto I, Rome, Italy., Caruso A; Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Brescia, Italy., Colizzi V; UNESCO Chair of Interdisciplinary Biotechnology and Bioethics, University of Rome Tor Vergata, Rome, Italy., Marcello A; Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy., Lourenço J; Faculdade de Medicina, Biomedical Research Center, Universidade Católica Portuguesa, Lisboa, Portugal., Ciccozzi M; Unit of Medical Statistics and Molecular Epidemiology, University of Campus Bio-Medico di Roma, Rome, Italy., Giovanetti M; Department of Sciences and Technologies for Sustainable Development and One Health, Universita Campus Bio-Medico di Roma, Rome, Italy; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil. Electronic address: giovanetti.marta@gmail.com.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Oct 09; Vol. 149, pp. 107262. Date of Electronic Publication: 2024 Oct 09.

Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study.

Autor: Fokam J; Faculty of Health Sciences, University of Buea, Buea P.O. Box 63, Cameroon.; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon.; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Bouba Y; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon.; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon.; Faculty of Medicine, UniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy., Ajeh RA; Faculty of Health Sciences, University of Buea, Buea P.O. Box 63, Cameroon.; HIV, Tuberculosis and Malaria Global Funds Subvention Coordination Unit (UCS), Ministry of Public Health, Yaoundé P.O. Box 2459, Cameroon., Guebiapsi DT; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Essamba S; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Zeh Meka AF; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Lifanda E; Health Office, United States Agency for International Development (USAID), Yaoundé P.O. Box 817, Cameroon., Ada RA; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Yakouba L; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Mbengono NB; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Djomo ARD; Health Office, United States Agency for International Development (USAID), Yaoundé P.O. Box 817, Cameroon., Tetang SN; Essos Hospital (CHE), National Social Welfare Centre, Yaoundé P.O. Box 5777, Cameroon., Sosso SM; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon., Babodo JC; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Ambomo OFN; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Temgoua EM; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Medouane C; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Atsinkou SN; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Mvogo JL; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Onana RM; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Anoubissi JD; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Ketchaji A; Division of Disease, Epidemic and Pandemic Control, Ministry of Public Health, Yaoundé P.O. Box 3038, Cameroon., Nka AD; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon., Gouissi DA; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon., Ka'e AC; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon.; Department of Experimental Medicine, University of Rome 'Tor Vergata', 00133 Rome, Italy., Fainguem NN; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon., Kamgaing RS; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon., Takou D; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon., Tchouaket MCT; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon., Semengue ENJ; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon., Atsama MA; Research Center on Emerging and Re-Emerging Diseases (CREMER), Yaoundé P.O. Box 13033, Cameroon., Nwobegahay J; Centre for Research and Military Health (CRESAR), Yaoundé P.O. Box 15939, Cameroon., Vuchas C; The Bamenda Center for Health Promotion and Research, Bamenda P.O. Box 586, Cameroon., Nsimen AN; The Bamenda Center for Health Promotion and Research, Bamenda P.O. Box 586, Cameroon., Bille BE; Retrovirology Laboratory, Laquintinie Hospital, Douala P.O. Box 4035, Cameroon., Gatchuessi SK; Fondation Sociale Suisse, Pette Hospital, Pette P.O. Box 65, Cameroon., Ateba FN; Mother-Child Centre, Chantal BIYA Foundation, Yaoundé P.O. Box 1936, Cameroon., Kesseng D; Mother-Child Centre, Chantal BIYA Foundation, Yaoundé P.O. Box 1936, Cameroon., Billong SC; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon., Armenia D; Faculty of Medicine, UniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy., Santoro MM; Department of Experimental Medicine, University of Rome 'Tor Vergata', 00133 Rome, Italy., Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome 'Tor Vergata', 00133 Rome, Italy., Koki PN; Mother-Child Centre, Chantal BIYA Foundation, Yaoundé P.O. Box 1936, Cameroon., Hamsatou HC; Central Technical Group, National AIDS Control Committee (NACC), Yaoundé P.O. Box 2459, Cameroon., Colizzi V; Faculty of Science and Technology, University of Bandjoun, Bandjoun P.O. Box 127, Cameroon., Ndjolo A; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon., Perno CF; Multimodal Medicine Laboratory, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy., Zoung-Kanyi Bissek AC; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.; Division of Health Operational Research, Ministry of Public Health, Yaoundé P.O. Box 1937, Cameroon.

Publikováno v: Biomedicines [Biomedicines] 2024 Sep 12; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 12.

TRIM5α 136Q, CCR5 Promoter 59029G And CCR264I Alleles Impact The Progression Of HIV In Children And Adolescents

Autor: Dambaya B, Nkenfou CN, Mekue L, Této G, Ngoufack N, Ambada G, Flobert N, Colizzi V, Alexis N

Publikováno v: The Application of Clinical Genetics, Vol Volume 12, Pp 203-211 (2019)

Béatrice Dambaya,1,2 Céline Nguefeu Nkenfou,1,3 Linda Mekue,1,4 Georges Této,1 Nicole Ngoufack,1,2 Georgia Ambada,1,2 Njiokou Flobert,1 Vittorio Colizzi,5 Ndjolo Alexis1,6 1Chantal BIYA International Reference Centre for Research on HIV/AIDS Preve

Externí odkaz: https://doaj.org/article/4dff9b372dde4915b15ac9e8025511aa

Computational and experimental validation of phthalocyanine and hypericin as effective SARS-CoV-2 fusion inhibitors.

Autor: Romeo A; Department of Biology, University of Tor Vergata, Rome, Italy., Cappelli G; Istituto per i Sistemi Biologici, Consiglio Nazionale delle Ricerche, Montelibretti, Rome, Italy., Iacovelli F; Department of Biology, University of Tor Vergata, Rome, Italy., Colizzi V; University of Tor Vergata, Rome, Italy., Falconi M; Department of Biology, University of Tor Vergata, Rome, Italy.

Publikováno v: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2024 May; Vol. 42 (8), pp. 3920-3934. Date of Electronic Publication: 2023 May 26.